- White House Launches New Strategy for U.S. President’s Malaria Initiative; Re-commits Efforts for Elimination
- Medicines for Malaria Venture (MMV) celebrates its 15th anniversary
- 2nd Generation Global Malaria Action Plan 2016-2030 Public Review
25 February 2015, Washington, D.C.: - Government leaders and key development stakeholders gathered at the White House this morning to celebrate progress made against malaria through the U.S. President’s Malaria Initiative (PMI)and to launch the program’s new strategy from 2015 to 2020. Highlighting U.S. commitment to malaria control and elimination, this strategy builds on successes that countries have achieved with PMI support, incorporates lessons learned from implementation of life-saving interventions and addresses existing challenges that threaten continued progress toward elimination.
Created in 2005 by the then president George W. Bush, PMI was established to curb the tide on the nearly 200 million cases of malaria affecting the African continent each year. Ten years later, PMI has proved to be a leading example of truly bi-partisan commitment to global health and foreign aid. Since its inception, PMI has helped distribute more than 80 million insecticide-treated nets, more than 65 million rapid diagnostic tests (RDTs) and more than 185 million antimalarial treatments to prevent, diagnose and treat malaria, respectively.
25 February 2015: - Product development partnership MMV met this week in Siem Reap, Cambodia for its 13th Stakeholders’ Meeting and celebrated fifteen years of harnessing public and private sector to produce affordable solutions to defeat malaria.
Looking back to the late 1990s, speakers highlighted that it was the creation of new tools that unlocked the unprecedented investment in malaria control and resulted in significant humanitarian impact over the last decade and a half. Looking forward, under the theme, “In Pursuit of Medicines for Malaria Elimination: Strong partnerships, high impact” , partners asserted that better, smarter innovations over the next 15 to 20 years will help realize the collective ambition towards a malaria free world.
"If MMV didn’t exist, we would have to invent it,” said Dr Nafo Traoré, EXD RBM Partnership.
17 February 2015: - "As we enter the final stages of our global consultation on this critical document, I would like to thank the Co-Chairs of the GMAP2 Task Force most sincerely for their commitment to guiding a process which has embraced collaboration, cooperation and consensus–building; the signature of true leadership. Together we can reach the 2030 malaria goals."
- Dr Fatoumata Nafo Traoré, Executive Director of the RBM Partnership
Statement from David Brandling Bennett, Bill & Melinda Gates Foundation and Bernard Nahlen, U.S Presidents Malaria Initiative; Co-Chairs of the GMAP2 Task Force.
After months of extensive enquiry and a world-wide consultation which targeted constituencies and stakeholders in all sectors of society, we are delighted to invite the broader development community to review the penultimate version of the 2nd generation RBM Global Malaria Action Plan - "Towards a Malaria-Free World: A Global Case for Investment and Action 2016-2030".
At the close of the MDG era, this forward-looking and pragmatic perspective from the Roll Back Malaria Partnership will help to guide the global malaria community as we collectively accelerate our efforts to defeat malaria.
"Towards a Malaria-Free World" is a companion document to the technical and policy recommendations in the WHO’s Global Technical Strategy for Malaria 2016–2030. It places the defeat of malaria firmly on the agenda of the new Sustainable Development Goals(SDGs), and offers a way forward to further reduce and eliminate malaria over the next fifteen years, charting the way for the further scale-up of cost-effective malaria interventions and helping to transform the lives of the poor, the marginalized and vulnerable hard to reach groups.
"Towards a Malaria-Free World" calls on the health sector and non-health sectors alike to strengthen their engagement in the fight against malaria and build a global partnership towards the achievement of the SDGs that makes all actors ( governments, civil society and private sector) accountable, and that truly leaves no one behind.
By making the case for investing in malaria control and elimination it provides malaria advocates at all levels with a highly valuable advocacy tool, while also directing future action in critical areas for the achievement of the 2030 malaria goals.
We are honoured to have been a part of this important consultative process and invite you to contribute your views to help improve this document and advance progress in the global fight against malaria.
The English review opens to the public today, Tuesday 17 February and runs until Wednesday 18 March 2015. Draft French and Spanish versions will be offered for public review from the week beginning 2 March until 31 March 2015.
Click here to participate in the public review of "Towards a Malaria-Free World"
(In English) (In Spanish)